To address the problem, the Weizmann team, which included Dr. Jehonathan Pinthus of Sheba Medical Center, Tel Hashomer, ???preconditioned??? the mice using one of two strategies already in use in some forms of cancer therapy: low doses of radiation or a specific chemotherapy drug.